Effective infectious keratitis treatment must eliminate
the pathogen,
reduce the inflammatory response, and prevent persistent damage to
the cornea. Infectious keratitis is generally treated with broad-spectrum
antibiotics; however, they have the risk of causing corneal epithelial
cell damage and drug resistance. In this study, we prepared a nanocomposite
(Arg-CQDs/pCur) from arginine (Arg)-derived carbon quantum dots (Arg-CQDs)
and polymeric curcumin (pCur). Partial carbonization of arginine hydrochloride
in the solid state by mild pyrolysis resulted in the formation of
CQDs, which exhibited enhanced antibacterial activity. pCur was formed
by the polymerization of curcumin, and further crosslinking reduced
its cytotoxicity and improved antioxidative, anti-inflammatory, and
pro-proliferative activities. The pCur in situ conjugated with Arg-CQDs
to form the Arg-CQDs/pCur nanocomposite, which showed a minimum inhibitory
concentration of ca. 10 μg mL–1, which was
>100-fold and >15-fold lower than that of the precursor arginine
and
curcumin, respectively, against Staphylococcus aureus, Escherichia coli, and Pseudomonas aeruginosa. The Arg-CQDs/pCur nanocomposite
with combined antibacterial, antioxidative, anti-inflammatory, pro-proliferative
properties, and long-term retention on cornea enabled synergistic
treatment of bacterial keratitis. In a rat model, it can effectively
treat P. aeruginosa-induced bacterial
keratitis at a concentration 4000-fold lower than the commercially
used drug, Sulmezole eye drops. Arg-CQDs/pCur nanocomposites have
great potential for application in antibacterial and anti-inflammatory
nanoformulations for clinical use to treat infectious diseases.